Keyphrases
Drug Therapy
100%
Early Tumor Response
100%
Diffuse Optical Tomography
100%
Drug Response
100%
Tumor
75%
Bevacizumab
50%
Total Hemoglobin
50%
Antiangiogenic Agents
50%
Patient-specific
25%
Tumor Response
25%
Non-invasive Imaging
25%
Magnetic Resonance Imaging
25%
Near-infrared Light
25%
Cost Reduction
25%
3D Imaging
25%
Cancer Therapeutics
25%
Imaging Modalities
25%
Effective Control
25%
Vascular Endothelial Growth Factor
25%
Deoxyhemoglobin
25%
Physiological Changes
25%
Bevacizumab Treatment
25%
Antiangiogenic Therapy
25%
Non-responders
25%
Tumor Subtype
25%
Lectin
25%
Small Animal Model
25%
Oxygenated Hemoglobin Concentration
25%
Non-ionizing Radiation
25%
Improved Patient Outcomes
25%
Xenograft Tumor
25%
Perfusion Study
25%
Duration of Therapy
25%
Drug Treatment
25%
Hemoglobin Level
25%
Tomography Imaging
25%
T2 Relaxometry
25%
Reduced Toxicity
25%
Medicine and Dentistry
Drug Therapy
100%
Neoplasm
100%
Optical Tomography
100%
Bevacizumab
50%
Angiogenesis Inhibitor
33%
Health Care Cost
16%
Malignant Neoplasm
16%
Magnetic Resonance Imaging
16%
Tumor Xenograft
16%
Antiangiogenic Therapy
16%
Lectin
16%
Vasculotropin
16%
Non-Ionizing Radiation
16%
Hemoglobin Determination
16%
Relaxometry
16%
3D Imaging
16%
Treatment Duration
16%